Risk Factors Identified for Late Recurrence of Liver Cancer
THURSDAY, Dec. 13, 2018 -- Late recurrence after hepatocellular carcinoma (HCC) resection is associated with sex, cirrhosis, and several aggressive tumor characteristics of the initial HCC, according to a study recently published in JAMA Surgery.
Xin-Fei Xu, M.D., from Second Military Medical University in Shanghai, and colleagues examined risk factors, patterns, and outcomes of late recurrence (more than two years) after curative liver resection for 734 HCC patients (88.8 percent male; mean age, 51.0 years) who underwent resection at six hospitals in China from 2001 through 2015.
The researchers found that 303 patients (41.3 percent) developed late recurrence. Male sex, cirrhosis, multiple tumors, satellite nodules, tumor size >5 cm, and macroscopic and microscopic vascular invasion were independent risk factors of late recurrence. For patients with late recurrence, 90.1 percent had only intrahepatic recurrence, and 9.9 percent had both intrahepatic and extrahepatic recurrence; none of the patients had only extrahepatic recurrence. One hundred sixty-five patients with late recurrence received potentially curative treatments (e.g., re-resection, transplant, and local ablation). Independent predictors of overall survival for patients with late recurrence included regular surveillance for postoperative recurrence (hazard ratio [HR], 0.470), cirrhosis (HR, 1.381), portal hypertension (HR, 2.424), Child-Pugh grade of B or C (HR, 1.376), Barcelona Clinic Liver Cancer stage B (HR, 1.304) and stage C (HR, 2.037), and potentially curative treatment (HR, 0.443).
"The patterns of late recurrence suggest that surveillance for recurrence after two years of surgery should be targeted to the liver, and postoperative surveillance improved the chance of further potentially curative treatments, with resultant improved survival outcomes in patients with late recurrence," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: December 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.